1
Jason M Vaughn, Justin R Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester dosage forms. BANNER LIFE SCIENCES, Brinks Gilson & Lione, May 2, 2017: US09636319 (2 worldwide citation)

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


2
Jason M Vaughn, Justin R Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester dosage forms. BANNER LIFE SCIENCES, Brinks Gilson & Lione, May 2, 2017: US09636318 (2 worldwide citation)

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


3
Jason M Vaughn, Justin R Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester dosage forms. BANNER LIFE SCIENCES, Brinks Gilson & Lione, February 14, 2017: US09566259 (2 worldwide citation)

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


4
Jason M Vaughn, Justin R Hughey, Tanesha Roberts, Tatyana Dyakonov, Sunil Agnihotri, Aqeel A Fatmi: Fumarate ester dosage forms. Banner Life Sciences, Brinks Gilson & Lione, November 14, 2017: US09814692

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One e ...


5
Jason M Vaughn, Michael M Crowley, Feng Zhang, John J Koleng, Justin M Keen, Justin R Hughey: Hydrophobic abuse deterrent delivery system. Meyertons Hood Kivlin Kowert & Goetzel PC, March 20, 2008: US20080069871-A1

Disclosed herein are oral dosage forms of therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described.


6
Jason M Vaughn, Michael M Crowley, Feng Zhang, John J Koleng, Justin M Keen, Justin R Hughey: Hydrophilic abuse deterrent delivery system. Meyertons Hood Kivlin Kowert & Goetzel PC, March 27, 2008: US20080075770-A1

Disclosed herein are oral dosage forms of therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described.


7
Jason M Vaughn, Michael M Crowley, Feng Zhang, John J Koleng, Justin M Keen, Justin R Hughey: Hydrophilic opioid abuse deterrent delivery system using opioid antagonists. Meyertons Hood Kivlin Kowert & Goetzel PC, March 27, 2008: US20080075771-A1

Disclosed herein are oral dosage forms of opioid therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described. The oral dosage forms may include one or more opioid ant ...


8
Jason M Vaughn, Michael M Crowley, Feng Zhang, John J Koleng, Justin M Keen, Justin R Hughey: Hydrophobic opioid abuse deterrent delivery system using opioid antagonists. Meyertons Hood Kivlin Kowert & Goetzel PC, March 27, 2008: US20080075768-A1

Disclosed herein are oral dosage forms of opioid therapeutic agents that are resistant to abuse and methods of their formulation. In particular, oral dosage forms that are resistant to dissolution in aqueous solutions of ethanol are described. The oral dosage forms may include one or more opioid ant ...


9
Ze ev Shaked, Justin R Hughey: Oral contraceptive dosage forms and methods of making such dosage forms. Meyertons Hood Kivlin Kowert & Goetzel PC, October 29, 2009: US20090269403-A1

Disclosed herein are oral dosage forms and methods of their use, in particular oral dosage systems for the delivery of drugs for use as a female oral contraceptive. In an embodiment, an oral dosage form includes a progestogen dispersed in an enteric polymer and an estrogen.



Click the thumbnails below to visualize the patent trend.